Explore 3 Stock Ideas & Industry Insights Download Free Report
Faron Pharmaceuticals is being watched for clinical development progress, financing capacity and regulatory milestones around its oncology pipeline. Attention is on trial data, patient recruitment, partner interest, cash runway and the ability to advance lead programmes while controlling development costs.
Kooth is being watched as investors assessDemandfor digital mental-health services, contract wins and the scalability of its technology platform. Attention is on public-sector funding, US and UK opportunities, user engagement,Revenuegrowth, cash generation and the conversion of partnerships into longer-term contracts.
Shield Therapeutics is in focus following its Q3 update showing continued growth in commercial prescriptions and US ACCRUFeR revenue, alongside the strategic shift to full US commercial control from 1 October. The company now expects a single-digit million-dollar operating loss for 2026 because of …
Time To ACT is being watched as investors assess progress in its healthcare and life-science strategy, funding requirements and commercialisation milestones. Attention is on programme development, partnerships, cash runway and the ability to convert intellectual property or platform capabilities into measurable commercial value.
Venture Life Group Plc — LSE:VLG closed 1.43% lower on12 November 2026, with the shares at 69.00p after a decrease of 1.00p on the day.
Anpario Plc — LSE:ANP closed 1.91% lower on12 November 2026, with the shares at 514.00p after a decrease of 10.00p on the day.
Worldwide Healthcare Trust shares rose 0.61% to around 409.0p on 12 Nov 2026, a gain of 2.50p, based on market data.
Convatec Group Plc (LSE:CTEC) shares rose 0.87% to 255.6p today, a gain of 2.2p. The medical products company remains in focus following its half-year results to 30 June 2026, which included a higherInterim Dividendand a new buyback.
OXB plc shares fell 1.08% to around 549.0p on 12 Nov 2026, a decline of 6.00p, based on market data.
AstraZeneca Plc (LSE:AZN) shares rose 0.99% to 14,034.0p today, a gain of 138.0p. The pharmaceutical group is the largest company by weighting in the FTSE 100 at 8.10%, and it remains in focus following its third-quarter results.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…